Convatec Group PLC

CTEC

Company Profile

  • Business description

    Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.

  • Contact

    20 Eastbourne Terrace
    7th Floor
    Paddington
    LondonW2 6LG
    GBR

    T: +44 7826447807

    E: [email protected]

    https://www.convatecgroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    10,000

Stocks News & Analysis

stocks

Markets brief: How will AI affect economic moats? Morningstar’s take on the new paradigm

A broad assessment of AI’s threats and opportunities leads to moat ratings changes for more than three dozen companies.
stocks

Baidu: Moat downgraded to none from wide; AI segment growth to offset search decline in long \run

We’ve also lowered our fair value estimate of Baidu stock.
stocks

What AI means for US software companies’ moats

We’re no longer certain that software firms will outperform over the next decade, but positive outcomes remain possible for names like Salesforce.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,823.6016.90-0.19%
CAC 407,915.3678.13-0.98%
DAX 4023,409.37181.66-0.77%
Dow JONES (US)47,740.80239.250.50%
FTSE 10010,249.5235.23-0.34%
HKSE25,408.46348.83-1.35%
NASDAQ22,695.95308.271.38%
Nikkei 22552,728.722,892.12-5.20%
NZX 50 Index13,236.20137.371.05%
S&P 5006,795.9955.970.83%
S&P/ASX 2008,599.003.30-0.04%
SSE Composite Index4,096.6027.59-0.67%

Market Movers